Enzymatics Licenses Enzyme Technology from Massey University Researcher | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzymatics has licensed technology from a New Zealand research facility that could allow genomic sequencing to be done more cheaply and quickly, Massey University said this week.

The enzyme technology was developed in the laboratory of Wayne Patrick, a senior lecturer in biochemistry at the Institute of Natural Sciences at the university, and involves a new method of engineering ligase by fusing DNA-binding proteins to the ligase enzyme.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.

Mar
30
Sponsored by
SeraCare

Our roundtable of industry experts will provide an overview of the current regulatory landscape for clinical genomics tests.

Apr
13
Sponsored by
SeraCare

In this webinar, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay.